Evidence map›Paper›PMID 27089919›Full record

ArticleCardiovascular research2016

Intracellular tortuosity underlies slow cAMP diffusion in adult ventricular myocytes.

Mark Richards, Oliver Lomas, Kees Jalink, Kerrie L Ford, Richard D Vaughan-Jones, Konstantinos Lefkimmiatis, Pawel Swietach

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. GPCR signaling via cAMP nanodomains.The Biochemical journal · 2025
    Review
  3. Review
  4. Article
  5. cAMP signaling: a remarkably regional affair.Trends in biochemical sciences · 2024
    Review
  6. Article
  7. Pore-like diffusion barriers in murine cardiac myocytes.bioRxiv : the preprint server for biology · 2023
    Article
  8. Review
  9. A multiscale model of the regulation of aquaporin 2 recycling.NPJ systems biology and applications · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Nanometric targeting of type 9 adenylyl cyclase in heart.Biochemical Society transactions · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mark RichardsBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford OX1 3PT, UK.
Oliver LomasBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford OX1 3PT, UK.
Kees JalinkDivision of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.
Kerrie L FordBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford OX1 3PT, UK.
Richard D Vaughan-JonesBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford OX1 3PT, UK.
Konstantinos LefkimmiatisBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford OX1 3PT, UK BHF Centre of Research Excellence, Oxford.
Pawel SwietachBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford OX1 3PT, UK pawel.swietach@dpag.ox.ac.uk.
Wellcome/Cancer Research UK Gurdon Institute · GBThe Netherlands Cancer Institute · NL

Funding

British Heart Foundation PG/12/2/29324British Heart Foundation RG/15/9/31534
6 · The paper itself

Abstract

aims3',5'-Cyclic adenosine monophosphate (cAMP) signals in the heart are often confined to concentration microdomains shaped by cAMP diffusion and enzymatic degradation. While the importance of phosphodiesterases (degradative enzymes) in sculpting cAMP microdomains is well established in cardiomyocytes, less is known about cAMP diffusivity (DcAMP) and factors affecting it. Many earlier studies have reported fast diffusivity, which argues against sharply defined microdomains. METHODS AND

results[cAMP] dynamics in the cytoplasm of adult rat ventricular myocytes were imaged using a fourth generation genetically encoded FRET-based sensor. The [cAMP]-response to the addition and removal of isoproterenol (β-adrenoceptor agonist) quantified the rates of cAMP synthesis and degradation. To obtain a read out of DcAMP, a stable [cAMP] gradient was generated using a microfluidic device which delivered agonist to one half of the myocyte only. After accounting for phosphodiesterase activity, DcAMP was calculated to be 32 µm(2)/s; an order of magnitude lower than in water. Diffusivity was independent of the amount of cAMP produced. Saturating cAMP-binding sites with the analogue 6-Bnz-cAMP did not accelerate DcAMP, arguing against a role of buffering in restricting cAMP mobility. cAMP diffused at a comparable rate to chemically unrelated but similar sized molecules, arguing for a common physical cause of restricted diffusivity. Lower mitochondrial density and order in neonatal cardiac myocytes allowed for faster diffusion, demonstrating the importance of mitochondria as physical barriers to cAMP mobility.

conclusionIn adult cardiac myocytes, tortuosity due to physical barriers, notably mitochondria, restricts cAMP diffusion to levels that are more compatible with microdomain signalling.

Indexed as

Second Messenger SystemsAdrenergic beta-AgonistsAlgorithmsAnimalsBiosensing TechniquesCyclic AMPCytoplasmDiffusionFluorescence Resonance Energy TransferHCT116 CellsHeart VentriclesHEK293 CellsHumansHydrogen-Ion ConcentrationIsoproterenolMaleAdrenergic beta-AgonistsCyclic AMPIsoproterenolN(6)-benzoyl-cyclic AMPcAMP microdomainsDiffusion reactionFRET sensorMathematical modellingMicrofluidics

Identifiers

PMID27089919
PMCPMC4872880
OpenAlexW2336121824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.